Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Adenuric TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: febuxostat
Brand name
(ARTG)
: ADENURIC febuxostat 80 mg tablets blister packConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Treatment of chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred (gouty arthritis and/or tophus formation) in adults with gout.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet
- Oral
- Pale yellow to yellow, film-coated rectangle shaped tablets with a breakline on one side and "80" engraved on the other side
Images


Images © Medicines Information Pty Ltd.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 28 tablets pack
- 4 tablets (sample pack) pack
- 8 tablets (sample pack) pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient febuxostat
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Febuxostat (Adenuric) tablets | Therapeutic Goods Administration (TGA)
Safety advisory – increased risk of death in gout patients with a history of major cardiovascular disease
Read more on TGA – Therapeutic Goods Administration website

Febuxostat — Arthritis Australia
Read more on Arthritis Australia website

Top results